Who
Nilda Mesa
Director
Company insider
Files Form 4 as: Director, United Therapeutics.
In numbers
- Trades disclosed
- 64
- Buys
- 0
- Sells
- 14
- Bought
- $0
- Sold
- $1.8M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 31 Oct 2018
- Last trade
- 14 Sep 2026
- Last filed
- 15 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Sep 2026filed 15 Sep 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Code M | $14K130 at $110.86 | filing |
| 14 Sep 2026filed 15 Sep 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $66K130 at $505.79 | filing |
| 14 Sep 2026filed 15 Sep 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $50K98 at $505.98 | filing |
| 14 Sep 2026filed 15 Sep 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —130 at $0.00 | filing |
| 14 Sep 2026filed 15 Sep 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —130 at $0.00 | filing |
| 14 Sep 2026filed 15 Sep 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Code M | $14K130 at $110.86 | filing |
| 14 Sep 2026filed 15 Sep 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $66K130 at $505.79 | filing |
| 14 Sep 2026filed 15 Sep 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $50K98 at $505.98 | filing |
| 22 Jul 2026filed 23 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —380 at $0.00 | filing |
| 22 Jul 2026filed 23 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,190 at $0.00 | filing |
| 22 Jul 2026filed 23 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —380 at $0.00 | filing |
| 22 Jul 2026filed 23 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,190 at $0.00 | filing |
| 9 Jul 2026filed 13 Jul 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Code M | —650 at $0.00 | filing |
| 9 Jul 2026filed 13 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —650 at $0.00 | filing |
| 9 Jul 2026filed 13 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —650 at $0.00 | filing |
| 9 Jul 2026filed 13 Jul 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Code M | —650 at $0.00 | filing |
| 12 May 2026filed 13 May 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $150K258 at $581.94 | filing |
| 12 May 2026filed 13 May 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $150K258 at $581.94 | filing |
| 9 Dec 2025filed 10 Dec 2025 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $90K187 at $481.63 | filing |
| 25 Jul 2025filed 28 Jul 2025 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —590 at $0.00 | filing |
News
Nilda Mesa Sells 228 Shares of United Therapeutics (NASDAQ:UTHR) Stocktickerreport.com · 15 Sep 2026Contrasting Xenon Pharmaceuticals (NASDAQ:XENE) and United Therapeutics (NASDAQ:UTHR)UTHR · dailypolitical.com · 18 Oct 2026United Therapeutics (NASDAQ: UTHR) general counsel sells 8,300 shares under planUTHR · themarketsdaily.com · 17 Oct 2026Head to Head Survey: Xenon Pharmaceuticals (NASDAQ:XENE) vs. United Therapeutics (NASDAQ:UTHR)UTHR · themarketsdaily.com · 12 Oct 2026
1 headline in the last 90 days name Nilda Mesa; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.